Advancing radiomics from contrast-enhanced mammography in breast cancer

Zardavas D, Irrthum A, Swanton C, Piccart M. Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol. 2015;12:381–94.

Article  CAS  PubMed  Google Scholar 

Qi Y-J, Su G-H, You C, Zhang X, Xiao Y, Jiang Y-Z, et al. Radiomics in breast cancer: Current advances and future directions. Cell Rep Med 2024;5:101719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Wang T, Guo S, Zhu S, Chen R, Zheng J, et al. Whole tumour- and subregion-based radiomics of contrast-enhanced mammography in differentiating HER2 expression status of invasive breast cancers: A double-centre pilot study. Br J Cancer. 2024;131:1613–22.

Su G-H, Xiao Y, You C, Zheng R-C, Zhao S, Sun S-Y, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci Adv. 2023;9:eadf0837.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, He Y, Li F, Han L, You C, Wang B. Segment anything in medical images. Nat Commun. 2024;15:654.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Z, Huang X, Cheng Z, Xu Z, Lin H, Liu C, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2023;308:e222830.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif